Open main menu
Blog HomeProductContact

Oncology

How HealthKey found 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial.
Case StudyDevice
•

How HealthKey found 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial.

US Urology Partners had one month before a J&J bladder cancer trial closed enrollment. HealthKey screened 431 patients and 353,000 medical records, found 16 with intermediate-risk NMIBC, and identified 2 eligible patients with 6 more staged for recurrence.

How HealthKey Screened Two Clinics in Parallel for a Phase 2 Bladder Cancer Trial.
Case StudyUrology
•

How HealthKey Screened Two Clinics in Parallel for a Phase 2 Bladder Cancer Trial.

US Urology Partners' care navigation team couldn't scale to every location. HealthKey screened 1,452 patients and 859,000 medical records across two clinics simultaneously, finding eligible patients at each site and enrolling both for CG Oncology's CORE-008 trial.

How Oregon Urology Institute Found 6 PSMA-DC Patients in 1 Week (After Enrolling Zero for Two Years)
Case Study
•

How Oregon Urology Institute Found 6 PSMA-DC Patients in 1 Week (After Enrolling Zero for Two Years)

Oregon Urology Institute searched for eligible clinical trial patients for the Novartis PSMA-DC study for two years with zero enrollments. HealthKey processed 5.2 million medical records, identified 6 eligible patients, 3 consented, and 1 enrolled.